Responses
Infectious diseases
Protocol
Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial
Compose a Response to This Article
Other responses
No responses have been published for this article.